HN saponin FCAS# 39524-13-5 |
| Cas No. | 39524-13-5 | SDF | File under preparation. |
| PubChem ID | 14101171.0 | Appearance | Powder |
| Formula | C41H66O13 | M.Wt | 767.0 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (4aS,6aR,6aS,6bR,8aR,9R,10S,12aR,14bS)-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxy-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate | ||
| SMILES | CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)CO)OC6C(C(C(CO6)O)O)O)C)C)C2C1)C)C(=O)OC7C(C(C(C(O7)CO)O)O)O)C | ||
| Standard InChIKey | UCVNVSOIAFGLPL-UUWFFIQNSA-N | ||
| Standard InChI | InChI=1S/C41H66O13/c1-36(2)13-15-41(35(50)54-34-32(49)30(47)29(46)24(18-42)52-34)16-14-39(5)21(22(41)17-36)7-8-26-37(3)11-10-27(53-33-31(48)28(45)23(44)19-51-33)38(4,20-43)25(37)9-12-40(26,39)6/h7,22-34,42-49H,8-20H2,1-6H3/t22-,23-,24+,25+,26+,27-,28-,29+,30-,31+,32+,33-,34-,37-,38-,39+,40+,41-/m0/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
HN saponin F Dilution Calculator
HN saponin F Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.3038 mL | 6.5189 mL | 13.0378 mL | 26.0756 mL | 32.5945 mL |
| 5 mM | 0.2608 mL | 1.3038 mL | 2.6076 mL | 5.2151 mL | 6.5189 mL |
| 10 mM | 0.1304 mL | 0.6519 mL | 1.3038 mL | 2.6076 mL | 3.2595 mL |
| 50 mM | 0.0261 mL | 0.1304 mL | 0.2608 mL | 0.5215 mL | 0.6519 mL |
| 100 mM | 0.013 mL | 0.0652 mL | 0.1304 mL | 0.2608 mL | 0.3259 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
- 3β,16-Dihydroxycleroda-4(18),13-dien-15,16-olide
Catalog No.:BCX2543
CAS No.:935293-69-9
- Bisnorponcitrin
Catalog No.:BCX2542
CAS No.:158443-92-6
- Trichotomoside
Catalog No.:BCX2541
CAS No.:881421-12-1
- 11,13-Dehydrolanuginolide
Catalog No.:BCX2540
CAS No.:50764-09-5
- Desinapoylhazaleanin A
Catalog No.:BCX2539
CAS No.:147742-26-5
- 1-Monolinolein
Catalog No.:BCX2538
CAS No.:2277-28-3
- Methyl 6-methoxycarbazole-3-carboxylate
Catalog No.:BCX2537
CAS No.:132922-58-8
- 1-O-Linolenoylglycerol
Catalog No.:BCX2536
CAS No.:18465-99-1
- Homoaromoline
Catalog No.:BCX2535
CAS No.:17132-74-0
- 12α-Hydroxyamoorastatone
Catalog No.:BCX2534
CAS No.:152013-84-8
- Eudesmane-1β, 6α,11-triol
Catalog No.:BCX2533
CAS No.:1804930-14-0
- Notoginsenoside SFt3
Catalog No.:BCX2532
CAS No.:1351360-27-4
- 14-Acetoxycostunolide
Catalog No.:BCX2545
CAS No.:2755714-73-7
- Drypetesin B
Catalog No.:BCX2546
CAS No.:1909225-87-1
- 4-Megastigmene-3,9-dione
Catalog No.:BCX2547
CAS No.:74233-41-3
- N-Methyl-N-phenethylbenzamide
Catalog No.:BCX2548
CAS No.:73355-77-8
- (±)-Regiolone
Catalog No.:BCX2549
CAS No.:62332-73-4
- threo-1,2-Bis(4-hydroxy-3-methoxyphenyl)-1-methoxypropan-3-ol
Catalog No.:BCX2550
CAS No.:110995-81-8
- 1,10-epi-Pyrethrosin
Catalog No.:BCX2551
CAS No.:88199-06-8
- 5'-Methoxydimethylmatairesinol
Catalog No.:BCX2552
CAS No.:64767-71-1
- Polylauioid G
Catalog No.:BCX2553
CAS No.:2332539-57-6
- Methyl (2E,6E)-10,11-dihydroxy-3,7,11-trimethyldodeca-2,6-dienoate
Catalog No.:BCX2554
CAS No.:36999-94-7
- Plantainoside A
Catalog No.:BCX2555
CAS No.:136172-59-3
- Rubescensin C
Catalog No.:BCX2556
CAS No.:81661-34-9
Pharmacokinetics study of asperosaponin VI and its metabolites cauloside A, HN saponin F and hederagenin.[Pubmed:24615060]
J Nat Med. 2014 Jul;68(3):488-97.
This experiment's with aim was to study the pharmacokinetics of asperosaponin VI and its three metabolites (cauloside A, HN saponin F and hederagenin) via a sensitive high performance liquid chromatography connected with electrospray ionization triple quadrupole mass spectrum (HPLC-ESI-MS/MS). Chromatographic separation was achieved on a reverse phase C18 column with a gradient mobile phase of CH3CN-water with 0.1 % HCOOH at a flow rate of 0.3 mL/min. Sample analysis was simultaneously performed with a multiple reaction monitoring mode using target determination ions at m/z 927.5 --> 603.4 for asperosaponin VI, m/z 811.1 --> 603.4 for cauloside A, m/z 649.4 --> 603.4 for HN saponin F, m/z 71.4 --> 393.3 for hederagenin and m/z 307.0 --> 161.1 for warfarin as the internal standard. The calibration curve was linear at the range of 0.25-500 ng/mL, and the lower limit of quantification was 0.25 ng/mL for each compound. While the precisely intra-assay and inter-assay variabilities were <9.5 and 7.8 %, respectively; accuracy was determined at the concentrations of 5, 25, 100 ng/mL for all the analytes with the relative standard deviation (%) no more than 15.0 %. Consequently, the validated method could be successfully and precisely applied to the pharmacokinetic study of asperosaponin VI and its metabolites. As a result, the pharmacokinetic parameters of cauloside A, HN saponin F and hederagenin such as T max were obtained at 9.33 +/- 2.49, 7.33 +/- 0.47 and 12.33 +/- 2.36 h, respectively.
[Chemical constituents in root of Hemerocallis fulva].[Pubmed:18536463]
Zhongguo Zhong Yao Za Zhi. 2008 Feb;33(3):269-72.
OBJECTIVE: To study the chemical constituents of the root of Hemerocallis fulva. METHOD: Compounds were isolated by repeated silica gel, Sephadex LH-20, MCI gel, etc. column chromatography and their structures were determined by spectral analyses and physicochemical properties. RESULT: From the n-butanol fraction of the EtOH extract of the roots of H. fulva, 9 glycosides were isolated and identified as sweroside (1), laganin (2), picraquassioside C (3), puerarin (4), 3'-methoxypuerarin (5), 7-hydro xylnaphthalide-O-beta-D-glucopyranoside (6), orcinol-3-O-beta-glucopyranoside (7), HN saponin F (8), hederagenin-3-0-beta D-glucopyranosyl-(1-3)-alpha-L-arabinopyranoside-28-O-beta-D-glucopyranosyl ester (9). CONCLUSION: Compounds 1-9 were isolated from the genus Hemerocallis for the first time.
In vitro anticomplementary activity of hederagenin saponins isolated from roots of Dipsacus asper.[Pubmed:10403139]
Arch Pharm Res. 1999 Jun;22(3):317-9.
Anticomplementary activity of hederagenin and related saponins isolated from Dipsacus asper was investigated in vitro. HN saponin F (3) was most potent with IC50 value of 3.7x10(-5) M followed by 3-O-beta-D-glucopyranosyl-(1->3)-alpha-L-rhamnopyranosyl-(1->2)-beta-L-+ ++arabi nopyranosyl hederagenin 28-O-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyrano side (8), 3-O-beta-L-arabinopyranosyl hederagenin 28-O-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranoside (5), dipsacus saponin A (4), and hederagenin (1) on the classical pathway (CP) of complement system, while the saponins 3-5 did not show the inhibition of hemolysis and rather increase the hemolysis on the alternative pathway (AP). However, all of C-3 monodesmosides [prosapogenin CP (2), dipsacus saponin B (6), and dipsacus saponin C (7)] evoked hemolysis directly on the erythrocytes.
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
